Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children

被引：24

作者：

Zaidi, MB

Zamora, E

Diaz, P

Tollefson, L

Fedorka-Cray, PJ

Headrick, ML

机构：

[1] Hosp Gen O Horan, Lab Invest, Merida 97000, Yucatan, Mexico

[2] US FDA, Ctr Vet Med, Rockville, MD 20857 USA

[3] ARS, Antimicrobial Resistance Res Unit, USDA, Russell Res Ctr, Atlanta, GA USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 06期

关键词：

D O I：

10.1128/AAC.47.6.1999-2001.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We determined the prevalence of, and risk factors for, fecal quinolone-resistant Escherichia coli (QREC) in 324 children from Yucatan, Mexico. QREC was higher in children with recent Salmonella infection (100%) than in children with diarrhea (61%) or healthy children (54%) (P = 0.007). Multivariate analysis identified recent hospitalization of a family member (P = 0.011, odds ratio [OR] = 5.1) and carriage of Salmonella (P = 0.004, OR = 3.7) as independent risk factors for QREC.

引用

收藏

页码：1999 / 2001

页数：3

相关论文

共 21 条

[1]

[Anonymous], 2000, M2A7 NCCLS

[2] Antimicrobial resistance in fecal flora: Longitudinal community-based surveillance of children from urban Mexico [J].

Calva, JJ ;

SifuentesOsornio, J ;

Ceron, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1699-1702

[3] Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis [J].

Carratala, J ;

FernandezSevilla, A ;

Dominguez, FTMA ;

Gudiol, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :503-505

[4] CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].

COHEN, SP ;

MCMURRY, LM ;

HOOPER, DC ;

WOLFSON, JS ;

LEVY, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325

[5] Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J].

Everett, MJ ;

Jin, YF ;

Ricci, V ;

Piddock, LJV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2380-2386

[6] Survey of Salmonella serotypes in feedlot cattle [J].

Fedorka-Cray, PJ ;

Dargatz, DA ;

Thomas, LA ;

Gray, JT .

JOURNAL OF FOOD PROTECTION, 1998, 61 (05) :525-530

[7] TRIMETHOPRIM-RESISTANT ESCHERICHIA-COLI IN HOUSEHOLDS OF CHILDREN ATTENDING DAY-CARE-CENTERS [J].

FORNASINI, M ;

REVES, RR ;

MURRAY, BE ;

MORROW, AL ;

PICKERING, LK .

JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :326-330

[8] Emergence and dissemination of quinolone-resistant Escherichia coli in the community [J].

Garau, J ;

Xercavins, M ;

Rodríguez-Carballeira, M ;

Gómez-Vera, JR ;

Coll, I ;

Vidal, D ;

Llovet, T ;

Ruíz-Bremón, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2736-2741

[9] Identification of mar mutants among quinolone-resistant clinical isolates of Escherichia coli [J].

Maneewannakul, K ;

Levy, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1695-1698

[10] Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria [J].

Poole, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2233-2241